However, in the PPP samples, TGF-β1 was lower in the cancer group than in the healthy controls; this maybe possibly due to sequestration of TGF-β1 by circulating platelets (24.2 versus 42.48 ng/mL, P < 0.001). The gene discussed is TGFB1; the disease is cancer.